BIOCAD
Konstantin Semenov is an experienced professional in the field of Clinical Quality Assurance and Quality Control, currently serving as the Head of Clinical QA and QC Department at BIOCAD since April 2019. Prior to this role, Konstantin has held the position of QA Director at IPHARMA LLC since December 2012, responsible for planning and implementing GCP QA systems, developing company SOPs, and conducting various audits. With a solid foundation in clinical monitoring as a former CRA, Konstantin's career includes extensive auditing experience as a Senior QA Auditor at ClinStar, where responsibilities encompassed conducting audits across multiple countries and therapeutic areas. Konstantin holds a Doctor of Medicine (M.D.) degree from St-Petersburg Medical State University.
This person is not in any teams
BIOCAD
6 followers
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.